Spots Global Cancer Trial Database for transoral surgery
Every month we try and update this database with for transoral surgery cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Adjuvant Treatment Deintensification After Transoral Surgery for Human Papillomavirus-Positive Squamous Cell Carcinoma | NCT05119036 | Squamous Cell C... HPV Positive Or... | 44 doses of rad... 54 doses of rad... | - | Indiana University | |
| Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer | NCT05388773 | Oropharynx Canc... | therapeutic con... laboratory biom... quality-of-life... intensity-modul... Cisplatin Carboplatin | 18 Years - | University of Pittsburgh | |
| Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer | NCT03715946 | Carcinoma, Squa... Oropharynx Squa... | Nivolumab Injec... Radiotherapy (R... | 18 Years - | University of Pittsburgh | |
| Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer | NCT03715946 | Carcinoma, Squa... Oropharynx Squa... | Nivolumab Injec... Radiotherapy (R... | 18 Years - | University of Pittsburgh | |
| Primary Radiotherapy Versus Primary Surgery for HPV-Associated Oropharyngeal Cancer | NCT03210103 | Oropharyngeal C... | Radiation Transoral Surge... | 18 Years - | Lawson Health Research Institute | |
| Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy | NCT04920344 | Clinical Stage ... Clinical Stage ... Clinical Stage ... Oropharyngeal H... | Transoral Surge... External Beam R... Cisplatin Incisional Tumo... Circulating tum... MD Anderson Dys... University of W... Euro-QOL 5 dime... Modified barium... | 18 Years - | Rutgers, The State University of New Jersey | |
| 2-day Prophylactic Antibiotic is Effective in Transoral Endoscopic Thyroidectomy | NCT04268407 | Thyroid Nodule | Amoxicillin Cla... | 20 Years - 80 Years | Chang Gung Memorial Hospital | |
| Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy | NCT04920344 | Clinical Stage ... Clinical Stage ... Clinical Stage ... Oropharyngeal H... | Transoral Surge... External Beam R... Cisplatin Incisional Tumo... Circulating tum... MD Anderson Dys... University of W... Euro-QOL 5 dime... Modified barium... | 18 Years - | Rutgers, The State University of New Jersey | |
| Adjuvant Treatment Deintensification After Transoral Surgery for Human Papillomavirus-Positive Squamous Cell Carcinoma | NCT05119036 | Squamous Cell C... HPV Positive Or... | 44 doses of rad... 54 doses of rad... | - | Indiana University | |
| Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery | NCT01612351 | Head and Neck C... Squamous Cell C... | Carboplatin Paclitaxel Lapatinib Cisplatin Cisplatin Ipsilateral Rad... Bilateral Radia... Transoral Surge... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical Cancer | NCT04630353 | HPV 16+ Confirm... | HB-201 IV HB-201 IV | 18 Years - | Hookipa Biotech GmbH | |
| Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer | NCT03715946 | Carcinoma, Squa... Oropharynx Squa... | Nivolumab Injec... Radiotherapy (R... | 18 Years - | University of Pittsburgh | |
| Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer | NCT01898494 | Human Papilloma... Stage III Squam... Stage IVA Squam... Stage IVB Squam... | Transoral surge... intensity-modul... cisplatin carboplatin | 18 Years - | Eastern Cooperative Oncology Group | |
| Primary Radiotherapy Versus Primary Surgery for HPV-Associated Oropharyngeal Cancer | NCT03210103 | Oropharyngeal C... | Radiation Transoral Surge... | 18 Years - | Lawson Health Research Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
